Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1)

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-03-04
DOI
https://doi.org/10.1186/s12885-026-15829-2
Primary Topic
Cancer and Skin Lesions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1)

Takayuki Fusumae, Kenji Kabashima, Yoichi Nakamura, Masayuki AMAGAI et al.
BMC Cancer
Cancer and Skin Lesions
article

Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1)

Takayuki Fusumae, Kenji Kabashima, Yoichi Nakamura, Masayuki AMAGAI, K. Namikawa, Yasuko Saito, T. Fujimura, Hiroshi Yamano- Uchi, Ikuko Hirai, Mariko Ogawa-Momohara, Naoya Yamazaki, Ryo Takemura, Takeru Funakoshi, Mana Kurimoto, Tatsuya Takenouchi, Atsushi Otsuka, Shoichiro Mori, Yuki Yamamoto, Keiji Tanese
article en

Abstract

No abstract available for this paper.
BMC Cancer
Toho University (JP), Wakayama Medical University (JP), Tohoku University (JP), Keio University (JP), Kyoto University (JP), National Cancer Centre Japan (JP), Niigata Cancer Center Hospital (JP), National Hospital Organization Kyushu Cancer Center (JP), Tohoku University Hospital (JP), Nagoya University (JP)
Openalex Percentile: Top 34%
Cancer and Skin Lesions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.